Jean‐Baptiste Bachet

25.8k total citations · 5 hit papers
213 papers, 13.5k citations indexed

About

Jean‐Baptiste Bachet is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jean‐Baptiste Bachet has authored 213 papers receiving a total of 13.5k indexed citations (citations by other indexed papers that have themselves been cited), including 188 papers in Oncology, 82 papers in Pulmonary and Respiratory Medicine and 58 papers in Cancer Research. Recurrent topics in Jean‐Baptiste Bachet's work include Pancreatic and Hepatic Oncology Research (91 papers), Colorectal Cancer Treatments and Studies (84 papers) and Cancer Genomics and Diagnostics (57 papers). Jean‐Baptiste Bachet is often cited by papers focused on Pancreatic and Hepatic Oncology Research (91 papers), Colorectal Cancer Treatments and Studies (84 papers) and Cancer Genomics and Diagnostics (57 papers). Jean‐Baptiste Bachet collaborates with scholars based in France, Belgium and Italy. Jean‐Baptiste Bachet's co-authors include Michel Ducreux, Marc Ychou, Olivier Bouché, Christelle de la Fouchardière, Françoise Desseigne, Pierre Michel, Pierre Laurent‐Puig, Jean‐Luc Raoul, Eric Assénat and Antoine Adenis and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Jean‐Baptiste Bachet

198 papers receiving 13.3k citations

Hit Papers

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic C... 2006 2026 2012 2019 2011 2006 2008 2009 2018 1000 2.0k 3.0k 4.0k 5.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
    2011 5.5k citations Marc Ychou, Olivier Bouché et al. profile →
  2. KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer
    2006 1.7k citations Astrid Lièvre, Jean‐Baptiste Bachet et al. Cancer Research profile →
  3. KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab
    2008 1.1k citations Astrid Lièvre, Jean‐Baptiste Bachet et al. Journal of Clinical Oncology profile →
  4. Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer
    2009 529 citations Pierre Laurent‐Puig, Anne Cayre et al. Journal of Clinical Oncology profile →
  5. Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features
    2018 301 citations Francesco Puleo, Rémy Nicolle et al. Gastroenterology profile →

Peers

Jean‐Baptiste Bachet
Antoine Adenis France
Jean‐Luc Van Laethem Belgium
Christelle de la Fouchardière France
Eric Assénat France
Joon Oh Park South Korea
Milind Javle United States
Jeeyun Lee South Korea
Rosine Guimbaud France
Antoine Hollebecque France
J. Randolph Hecht United States
Antoine Adenis France
Jean‐Baptiste Bachet
Citations per year, relative to Jean‐Baptiste Bachet Jean‐Baptiste Bachet (= 1×) peers Antoine Adenis

Countries citing papers authored by Jean‐Baptiste Bachet

Since Specialization
Citations

This map shows the geographic impact of Jean‐Baptiste Bachet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Baptiste Bachet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Baptiste Bachet more than expected).

Fields of papers citing papers by Jean‐Baptiste Bachet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Baptiste Bachet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Baptiste Bachet. The network helps show where Jean‐Baptiste Bachet may publish in the future.

Co-authorship network of co-authors of Jean‐Baptiste Bachet

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Baptiste Bachet. A scholar is included among the top collaborators of Jean‐Baptiste Bachet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Baptiste Bachet. Jean‐Baptiste Bachet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ducreux, Michel, Yves Rinaldi, Frédéric Di Fiore, et al.. (2025). PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma. Journal of Clinical Oncology. 43(20). 2255–2264. 3 indexed citations
2.
Bachet, Jean‐Baptiste, Déwi Vernerey, Christophe Boisson, et al.. (2024). 532P G-CSF secondary prophylaxis in patients (pts) with metastatic colorectal cancer (mCRC) treated with trifluridine/tipiracil (FTD/TPI): The GERCOR LONGBOARD study. Annals of Oncology. 35. S447–S447. 1 indexed citations
3.
Meurisse, Aurélia, Pascal Artru, Thierry Lecomte, et al.. (2024). 517P Circulating tumor DNA driving anti-EGFR rechallenge therapy in metastatic colorectal cancer: The RASINTRO prospective multicenter study. Annals of Oncology. 35. S438–S438. 1 indexed citations
4.
Grégory, Jules, Frédéric Bert, Anna Pellat, et al.. (2024). Diagnosis and treatment of bacterial peritonitis in patients with gastrointestinal cancer: an observational multicenter study. Therapeutic Advances in Medical Oncology. 16. 12703176–12703176.
5.
Duval, M., Jean‐Baptiste Bachet, Claire Goumard, et al.. (2024). Performances of preoperative CT scan to predict the pTN stage for MSI/dMMR localized colon cancers. ESMO Open. 9(8). 103678–103678. 6 indexed citations
6.
Cros, Jérôme, Jean‐Luc Van Laethem, Jean‐François Emile, et al.. (2023). Trop-2 is a ubiquitous and promising target in pancreatic adenocarcinoma. Clinics and Research in Hepatology and Gastroenterology. 47(4). 102108–102108. 7 indexed citations
7.
8.
Benoist, Stéphane, Patrick Devos, Stéphanie Truant, et al.. (2022). Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study. World Journal of Surgical Oncology. 20(1). 131–131. 15 indexed citations
9.
10.
Boulin, Mathieu, Karine Le Malicot, Julien Taı̈eb, et al.. (2022). Impact of G-CSF Prophylaxis on Chemotherapy Dose-Intensity, Link Between Dose-Intensity and Survival in Patients with Metastatic Pancreatic Adenocarcinoma. The Oncologist. 27(7). e571–e579. 3 indexed citations
11.
12.
Bachet, Jean‐Baptiste, Hélène Blons, Pascal Hammel, et al.. (2020). Circulating Tumor DNA is Prognostic and Potentially Predictive of Eryaspase Efficacy in Second-line in Patients with Advanced Pancreatic Adenocarcinoma. Clinical Cancer Research. 26(19). 5208–5216. 31 indexed citations
13.
Pernot, Simon, Olivier Dubreuil, Thomas Aparicio, et al.. (2018). Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study. British Journal of Cancer. 119(4). 424–428. 24 indexed citations
14.
Puleo, Francesco, Rémy Nicolle, Yuna Blum, et al.. (2018). Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features. Gastroenterology. 155(6). 1999–2013.e3. 301 indexed citations breakdown →
15.
Bressy, Christian, Sophie Lac, Jérémy Nigri, et al.. (2017). LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker. Cancer Research. 78(4). 909–921. 82 indexed citations
16.
Pietrasz, Daniel, Nicolas Pécuchet, Fanny Garlan, et al.. (2016). Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker. Clinical Cancer Research. 23(1). 116–123. 183 indexed citations
17.
Puleo, Francesco, Pieter Demetter, Pierre Eisendrath, et al.. (2016). Feasibility of Immunohistochemistry on Endoscopic Ultrasound Fine-Needle Aspiration Samples for Evaluating Predictive Biomarkers in Pancreatic Cancer Management. Pancreas. 45(9). e50–e52. 1 indexed citations
18.
Pietrasz, Daniel, Nicolas Pécuchet, Elizabeth Fabre, et al.. (2016). Quel avenir pour l’ADN tumoral circulant ? État des lieux et perspectives dans les cancers colorectaux, pulmonaires non à petites cellules et pancréatiques. Bulletin du Cancer. 103(1). 55–65. 5 indexed citations
19.
Laurent‐Puig, Pierre, Anne Cayre, Gilles Manceau, et al.. (2009). Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer. Journal of Clinical Oncology. 27(35). 5924–5930. 529 indexed citations breakdown →
20.
Lièvre, Astrid, Jean‐Baptiste Bachet, Valérie Boige, et al.. (2008). KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab. Journal of Clinical Oncology. 26(3). 374–379. 1141 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antoine Adenis Breakdown of academic impact, for papers by Jean‐Luc Van Laethem Breakdown of academic impact, for papers by Christelle de la Fouchardière Breakdown of academic impact, for papers by Eric Assénat Breakdown of academic impact, for papers by Joon Oh Park Breakdown of academic impact, for papers by Milind Javle Breakdown of academic impact, for papers by Jeeyun Lee Breakdown of academic impact, for papers by Rosine Guimbaud Breakdown of academic impact, for papers by Antoine Hollebecque Breakdown of academic impact, for papers by J. Randolph Hecht
Rankless by CCL
2026